Skip to content
Maui Sky – Lifestyle
Author:
Nona Biosciences
Nona Biosciences Successfully Develops World’s First Language Model Trained on Fully Human Heavy-Chain-Only Antibodies
September 16, 2026
Nona Biosciences Enters Research Collaboration with the Medical University of Vienna to Advance Fully Human Antibody Development for Infectious Diseases
July 22, 2026
Nona Biosciences Appoints Dr. Peng Wang as Chief Operating Officer to Advance Platform Capabilities and Drive Operational Excellence
July 2, 2026
Nona Biosciences and Lonza Enter Strategic Collaboration to Develop Best-in-Class Single-Domain Antibody-Based BBB-Crossing Technology for CNS Diseases
July 1, 2026